Reich & Binstock
Free Initial Consultation Call
713-352-7883
713-352-7883

Posts tagged "#diabetes"

FDA issues ketoacidosis warning for 3 diabetes drugs

The U.S. Food and Drug Administration on May 15 issued a warning about the use of three medicines that have been used in the treatment of Type-2 diabetes. The drugs Invokana (canagliflozin), Farxiga (dapagliflozin) and Jardiance (empagliflozin) "may lead to ketoacidosis, a serious condition where the body produces high levels of blood acids called ketones that may require hospitalization," according to the agency.

FDA issues ketoacidosis warning for 3 diabetes drugs

The U.S. Food and Drug Administration on May 15 issued a warning about the use of three medicines that have been used in the treatment of Type-2 diabetes. The drugs Invokana (canagliflozin), Farxiga (dapagliflozin) and Jardiance (empagliflozin) "may lead to ketoacidosis, a serious condition where the body produces high levels of blood acids called ketones that may require hospitalization," according to the agency.

Panel may centralize Lipitor lawsuits

Litigants in Lipitor product liability lawsuits, precisely the type of people we fight for here at Reich & Binstock, may see their cases transferred to the U.S. District Court for the Southern District of South Carolina. The panel took up at its Feb. 6 hearing a motion to consolidate before one federal trial court Lipitor lawsuits from a dozen states.

Panel may centralize Lipitor lawsuits

Litigants in Lipitor product liability lawsuits, precisely the type of people we fight for here at Reich & Binstock, may see their cases transferred to the U.S. District Court for the Southern District of South Carolina. The panel took up at its Feb. 6 hearing a motion to consolidate before one federal trial court Lipitor lawsuits from a dozen states.

Panel may transfer nearly 100 Lipitor lawsuits

Nearly 100 diabetic plaintiffs in Lipitor lawsuits, more than 80 of which from the federal Central District of California, will find out in June whether their cases will be adjudicated in the courts in which those lawsuits were filed. The U.S. Judicial Panel on Multidistrict Litigation will rule after its May 29 hearing in Chicago on whether plaintiffs' opposition to transferring these Lipitor lawsuits is just.

Panel may transfer nearly 100 Lipitor lawsuits

Nearly 100 diabetic plaintiffs in Lipitor lawsuits, more than 80 of which from the federal Central District of California, will find out in June whether their cases will be adjudicated in the courts in which those lawsuits were filed. The U.S. Judicial Panel on Multidistrict Litigation will rule after its May 29 hearing in Chicago on whether plaintiffs' opposition to transferring these Lipitor lawsuits is just.

Federal Lipitor lawsuits pile up fast

If you were diagnosed with Type-2 diabetes after using the cholesterol-lowering drug Lipitor, there is a chance you are entitled to compensation for your diabetes injury. One way to find out whether there is a case for a Lipitor lawsuit is to get a free consultation from one of the experienced Lipitor attorneys at Reich & Binstock.

Federal Lipitor lawsuits pile up fast

If you were diagnosed with Type-2 diabetes after using the cholesterol-lowering drug Lipitor, there is a chance you are entitled to compensation for your diabetes injury. One way to find out whether there is a case for a Lipitor lawsuit is to get a free consultation from one of the experienced Lipitor attorneys at Reich & Binstock.

Lipitor singled out itself in diabetes risk

Back in January, the U.S. Food and Drug Administration updated its safety advisories in regard to the anti-cholesterol drug Lipitor and other so-called "statin" drugs. It read, "People being treated with statins may have an increased risk of raised blood sugar levels and the development of Type 2 diabetes."

Lipitor singled out itself in diabetes risk

Back in January, the U.S. Food and Drug Administration updated its safety advisories in regard to the anti-cholesterol drug Lipitor and other so-called "statin" drugs. It read, "People being treated with statins may have an increased risk of raised blood sugar levels and the development of Type 2 diabetes."

Email Us For A Response

Contact Us For a Free Legal Consultation There is a never a fee unless we recover on your behalf.

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

Privacy Policy

Call for a Free Legal Consultation: 713-352-7883
Reich & Binstock - Pharmaceutical Injury & Class Action Lawyers

4265 San Felipe
Suite 1000
Houston, TX 77027

Toll Free: 877-643-3099
Phone: 713-352-7883
Fax: 713-623-8724
Houston Law Office Map